JNS Holdings Corporation Files Freedom of

New Post Public Reply Private Reply Replies (0) Message Board
junewong

JNS Holdings Corporation Files Freedom of Information Request

Jns Holdings Corporation (PL) (USOTC:JNSH)
Historical Stock Chart

1 Month : From Jan 2013 to Feb 2013

Click Here for more Jns Holdings Corporation (PL) Charts.

JNS Holdings Corporation (OTC Markets Group: JNSH) today announced that JNS has filed a freedom of information request and received said information from the City of Chicago pertaining to an existing grant agreement. The company has made this request as part of its intense due diligence as it readies itself to tender an unsolicited offer to take over and complete said agreement in its entirety.

The referenced agreement pertains to the stalled electrical vehicle power stations that were awarded to San Diego based 350Green, LLC in February of 2011 with a targeted completion date for the end of the same year. To date 350Green, LLC has installed only 168 of the 274 EV chargers from the existing grant agreement and has stopped work due to financial issues.

JNS Power & Control Systems, Inc. an Arlington Heights, IL based contractor www.jnspower.com with extensive experience within the local market will make the unsolicited offer to 350Green, LLC within the next 10 business days to acquire their entire rights of the agreement so that the project can be brought to fruition.

“We believe that this is not only the future for energy independence we also believe the biggest limitation for drivers considering EV’s is the absence of a reliable network,” said Brian Howe, CEO.

About JNS Holdings Corporation:

JNS Holdings focuses on building solid growth for our investors and shareholders through expansion of our core businesses while seeking additional strategic opportunities. The company's current capitalization is Total Authorized Shares of 122,000,000 with a Public Float of 63,504,182.

This press release does not constitute an offer of any securities for sale. This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements involve certain risks and uncertainties that could cause actual results to differ. All forward-looking statements in this press release are based on information available to the company as of the date hereof, and the company undertakes no obligation to update forward-looking statements to reflect events or circumstances occurring after the date of this press release.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Exploring the $2.7 Billion Bid for Papa John’s: An Investment Insight

Updated Category News Views 229

Papa John’s $2.7 Billion Takeover Bid: Insights into Potential Value Recently, shares of Papa John’s International Inc (NASDAQ:PZZA) experienced a notable surge, leading to a halt in trading due to high volatility. This surprising movement came in light of credible reports suggesting a take-private cash offer of $65 per share from TriArtisan Capital Advisors, totaling...

Continue Reading
Key Highlights from Octopus Apollo VCT plc AGM Results

Updated Category News Views 105

Octopus Apollo VCT plc AGM Results Overview Octopus Apollo VCT plc recently conducted its Annual General Meeting (AGM), showcasing significant engagement from shareholders. The meeting aimed to discuss key resolutions impacting the future direction of the company. Voting Outcomes of the AGM The company disclosed that all resolutions were successfully passed during the...

Continue Reading
Carisma Therapeutics Showcases Strong Financial Performance

Updated Category News Views 104

Carisma Therapeutics Showcases Strong Financial Performance Carisma Therapeutics Inc. (NASDAQ: CARM), a clinical-stage biopharmaceutical company, recently released its financial performance for the third quarter of 2024. With a focus on developing innovative immunotherapies, Carisma provided insight into its ongoing projects. Key Developments and Milestones Carisma's...

Continue Reading
Epinephrine Market Growth Insights and Future Potential

Updated Category News Views 112

Overview of the Epinephrine Market The global epinephrine market is on a significant upswing, with recent evaluations estimating its value at USD 3.11 billion and a projected growth to approximately USD 6.39 billion within the next decade. As a critical hormone and neurotransmitter produced by the adrenal glands, epinephrine is essential in treating severe allergic...

Continue Reading
Canadian North Resources Achieves Major Milestones in Q2 2025

Updated Category News Views 183

Canadian North Resources Makes Significant Progress in Operational Strategy Highlights: Canadian North has expanded its bio-metallurgical programs significantly, achieving impressive nickel and cobalt extraction rates through innovative bio-leaching tests. The focus remains on extracting copper and other precious group elements (PGE) metals from the Ferguson Lake Project....

Continue Reading